New Weekly Impact Insight
Tanaha Hairston, MBA
Impact Investor | Building Access to Diverse Impact Investment Opportunities Across Asset Classes & Community | Founder of RISE Impact Investing Community
Every week, we highlight a unique, fascinating investment opportunity and, most importantly, demonstrate how we analyze it.
?? A company focused on treating medical conditions related to bone ??
?? Why This Company? This company has developed novel chemistry that selectively delivers pharmaceuticals to a specific tissue. The advantage of this technology is that exposure to the active pharmaceutical occurs only in the targeted tissues, thereby eliminating toxicity to unrelated organs.
?? Mission: The initiation of clinical trials and the advancement of its therapeutic solutions are indicative of the company's expansion in its operational activities within the biotechnology and health care industry.
?? Impact Goals: The company is developing innovative drugs that can selectively distribute to musculoskeletal tissue. These drugs carry payloads such as small-molecule hormones or anti-cancer agents. Its first clinical program utilizes tissue-selective distribution to deliver prostaglandin, a potent hormone that triggers the body's own regenerative process, to musculoskeletal tissue to renew and repair muscle and bone. The drug-conjugate carries the drug in an inactive state until it binds to the bone. After the targeting moiety binds to bone, the drug is released where it is received by mesenchymal stem cells, stimulating their maturation to several lineages.
?? Funding: This company has recently raised $15 million for Phase 1 clinical trials, indicating an influx of capital to support its research and development efforts. Additionally, the company has begun dosing patients with its investigational drug, which is designed to accelerate the healing of bone fractures, suggesting progress in its product pipeline.
???? Women Exposure: Bone health is important for women. 50% of post-menopausal women have bone loss. While existing treatments can slow down bone degeneration, there is currently no safe way to reverse bone loss. The body’s skeleton renews itself only every 10 years.
???? Team and Expertise
?? My Thoughts: In September 2023, the company announced the successful dosing of the first human participants in a randomized, double-blind, placebo-controlled clinical trial. The company’s work is going to contribute to societal health and wellbeing, bringing potential broader impacts of its innovations. So, it's beneficial for investors to invest in such companies at an early pre-revenue stage before its exit strategy, such as acquisitions, mergers, or initial public offerings (IPOs).
??? Tags: #InnovationforImpact #Tech4All #HealthCare #HealthAccess #HealthTech #Biotech #SocialInfrastructure
Questions to consider:
领英推荐
Look around at the real estate and businesses out there—there are ones that prioritize making the world better for you and your generation, and some that don't. We want to support those that prioritize these principles. We look for solid plans with great people leading.
JOIN THE R.I.S.E. THE MOVEMENT COMMUNITY!
Book a call with us today! When you sign up to become a member of R.I.S.E. The Movement, you gain access to dozens of educational tools including courses, blogs, live and virtual events, insights from expert investors, and a community of women investors just like you ready to support and encourage you along your investment journey!
At R.I.S.E (Rewarding Investments Smart Education) we are committed to educating and providing community for women investors at every stage of their impact investment journey. We believe the key to success lies in education, informed decision-making, and using investments to make an impact.